Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 4
2022 3
2023 2
2024 7
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Is the decrement pattern in myasthenia gravis due to muscle-specific kinase antibodies different to that due to acetylcholine receptor antibodies?
Pegat A, Gavoille A, Bonjour M, Cluse F, Moussy M, Svahn J, Kouton L, Grapperon AM, Verschueren A, Delmont E, Salort-Campana E, Attarian S, Fortanier E, Bouhour F. Pegat A, et al. Among authors: bonjour m. Neurophysiol Clin. 2025 Nov;55(6):103092. doi: 10.1016/j.neucli.2025.103092. Epub 2025 Jul 31. Neurophysiol Clin. 2025. PMID: 40743586 Free article.
Contralateral R1 response in blink reflex in patients with amyotrophic lateral sclerosis.
Theuriet J, Bohic A, Bonjour M, Bernard E, Cluse F, Svahn J, Jomir L, Vallet AE, Demia M, Roux L, Bârsan IC, Alves L, Dion M, Meens L, Moussy M, Bouhour F, Péréon Y, Pegat A. Theuriet J, et al. Among authors: bonjour m. Clin Neurophysiol Pract. 2025 Feb 22;10:47-51. doi: 10.1016/j.cnp.2025.02.005. eCollection 2025. Clin Neurophysiol Pract. 2025. PMID: 40092496 Free PMC article.
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.
Piffoux M, Leary A, Follana P, Abdeddaim C, Joly F, Bin S, Bonjour M, Boulai A, Callens C, Villeneuve L, Alexandre M, Schwiertz V, Freyer G, Rodrigues M, You B. Piffoux M, et al. Among authors: bonjour m. Nat Commun. 2025 Feb 20;16(1):1821. doi: 10.1038/s41467-025-56914-7. Nat Commun. 2025. PMID: 39979249 Free PMC article. Clinical Trial.
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).
Walter T, Lecomte T, Hadoux J, Niccoli P, Saban-Roche L, Gaye E, Guimbaud R, Baconnier M, Hautefeuille V, Do Cao C, Petorin C, Hentic O, Perrier M, Aparicio T, Scoazec JY, Bonjour M, Gibert B, Hervieu V, Poncet D, Barritault M, Gerard L, Durand A; “Groupe d’étude des tumeurs endocrines (GTE)” and the French ENDOCAN-RENATEN network. Walter T, et al. Among authors: bonjour m. J Clin Oncol. 2025 Mar 10;43(8):960-971. doi: 10.1200/JCO.23.02724. Epub 2024 Nov 25. J Clin Oncol. 2025. PMID: 39586038 Clinical Trial.
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta-analysis of an N-of-1 trial.
Laurencin C, Poujois A, Bonjour M, Demily C, Klinger H, Roze E, Leclert V, Danaila T, Langlois-Jacques C, Couchonnal E, Woimant F, Obadia MA, Perez G, Pernon M, Blanchet L, Broussolle E, Vidailhet M, Kassai B, Moro E, Karachi C, Polo G, Grabli D, Portefaix A, Thobois S. Laurencin C, et al. Among authors: bonjour m. Eur J Neurol. 2025 Jan;32(1):e16524. doi: 10.1111/ene.16524. Epub 2024 Oct 29. Eur J Neurol. 2025. PMID: 39468897 Free PMC article.
24 results